These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 10378581

  • 1. Improvement of pulmonary hypertension after liver transplantation.
    Schott R, Chaouat A, Launoy A, Pottecher T, Weitzenblum E.
    Chest; 1999 Jun; 115(6):1748-9. PubMed ID: 10378581
    [Abstract] [Full Text] [Related]

  • 2. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation.
    Krowka MJ, Plevak DJ, Findlay JY, Rosen CB, Wiesner RH, Krom RA.
    Liver Transpl; 2000 Jul; 6(4):443-50. PubMed ID: 10915166
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension.
    Kähler CM, Graziadei I, Wiedermann CJ, Kneussl MP, Vogel W.
    Wien Klin Wochenschr; 2000 Jul 28; 112(14):637-40. PubMed ID: 11008327
    [Abstract] [Full Text] [Related]

  • 6. Living-donor liver transplantation for moderate or severe porto-pulmonary hypertension accompanied by pulmonary arterial hypertension: a single-centre experience over 2 decades in Japan.
    Ogawa E, Hori T, Doi H, Segawa H, Uemoto S.
    J Hepatobiliary Pancreat Sci; 2012 Nov 28; 19(6):638-49. PubMed ID: 22086457
    [Abstract] [Full Text] [Related]

  • 7. Progressive portopulmonary hypertension after liver transplantation treated with epoprostenol.
    Rafanan AL, Maurer J, Mehta AC, Schilz R.
    Chest; 2000 Nov 28; 118(5):1497-500. PubMed ID: 11083710
    [Abstract] [Full Text] [Related]

  • 8. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database.
    Krowka MJ, Mandell MS, Ramsay MA, Kawut SM, Fallon MB, Manzarbeitia C, Pardo M, Marotta P, Uemoto S, Stoffel MP, Benson JT.
    Liver Transpl; 2004 Feb 28; 10(2):174-82. PubMed ID: 14762853
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rapid normalization of portopulmonary hypertension after living donor liver transplantation.
    Sugimachi K, Soejima Y, Morita K, Ueda S, Fukuhara T, Nagata S, Ikegami T, Taketomi A, Maehara Y.
    Transplant Proc; 2009 Jun 28; 41(5):1976-8. PubMed ID: 19545772
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Oral pulmonary vasoactive drugs achieve hemodynamic eligibility for liver transplantation in portopulmonary hypertension.
    Legros L, Chabanne C, Camus C, Fournet M, Houssel-Debry P, Latournerie M, Jezequel C, Rayar M, Boudjema K, Guyader D, Bardou-Jacquet E.
    Dig Liver Dis; 2017 Mar 28; 49(3):301-307. PubMed ID: 27840058
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol.
    Fix OK, Bass NM, De Marco T, Merriman RB.
    Liver Transpl; 2007 Jun 28; 13(6):875-85. PubMed ID: 17539008
    [Abstract] [Full Text] [Related]

  • 15. Does Portopulmonary Hypertension Impede Liver Transplantation in Cirrhotic Patients? A French Multicentric Retrospective Study.
    Reymond M, Barbier L, Salame E, Besh C, Dumortier J, Pageaux GP, Bureau C, Dharancy S, Vanlemmens C, Abergel A, Woehl Jaegle ML, Magro P, Patat F, Laurent E, Perarnau JM.
    Transplantation; 2018 Apr 28; 102(4):616-622. PubMed ID: 29077657
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Diagnosis, Treatment, and Management of Orthotopic Liver Transplant Candidates With Portopulmonary Hypertension.
    Koulava A, Sannani A, Levine A, Gupta CA, Khanal S, Frishman W, Bodin R, Wolf DC, Aronow WS, Lanier GM.
    Cardiol Rev; 2018 Apr 28; 26(4):169-176. PubMed ID: 29608499
    [Abstract] [Full Text] [Related]

  • 18. Volume-mediated pulmonary responses in liver transplant candidates.
    Kuo PC, Schroeder RA, Vagelos RH, Valantine H, Garcia G, Alfrey EJ, Haddow G, Dafoe DC.
    Clin Transplant; 1996 Dec 28; 10(6 Pt 1):521-7. PubMed ID: 8996773
    [Abstract] [Full Text] [Related]

  • 19. Hepatopulmonary syndrome and portopulmonary hypertension in the model for end-stage liver disease (MELD) era.
    Mandell MS.
    Liver Transpl; 2004 Oct 28; 10(10 Suppl 2):S54-8. PubMed ID: 15382220
    [Abstract] [Full Text] [Related]

  • 20. [Pulmonary hypertension complicating portal hypertension: portopulmonary hypertension].
    Katsuta Y, Zhang XJ, Aramaki T.
    Nihon Rinsho; 2001 Jun 28; 59(6):1186-92. PubMed ID: 11411134
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.